Does first-line treatment impact the cost-effectiveness of second-line treatment for elderly metastatic colon cancer patients?

被引：0
|
作者：
Mullins, C. Daniel
Woldemichael, Andinet
Zheng, Zhiyuan
Onukwugha, Ebere
Seal, Brian S.
Hanna, Nader
机构：
[1] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Bayer HealthCare Pharmaceut, Wayne, NJ USA
[5] Univ Maryland, Dept Surg, Div Gen & Oncol Surg, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Does First-line Treatment Impact the Cost Effectiveness of Second-line Treatment for Elderly Metastatic Colon Cancer Patients?
    Mullins, C.
    Woldemichael, A.
    Zheng, Z.
    Onukwugha, E.
    Seal, B. S.
    Hanna, N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S141 - S141
  • [2] Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
    Zheng, Zhiyuan
    Onukwugha, Eberechukwu
    Hanna, Nader
    Bikov, Kaloyan
    Seal, Brian
    Mullins, C. Daniel
    [J]. ADVANCES IN THERAPY, 2014, 31 (07) : 724 - 734
  • [3] Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
    Zhiyuan Zheng
    Eberechukwu Onukwugha
    Nader Hanna
    Kaloyan Bikov
    Brian Seal
    C. Daniel Mullins
    [J]. Advances in Therapy, 2014, 31 : 724 - 734
  • [4] How do first-line treatment and other factors affect the receipt of second-line treatment for elderly metastatic colon cancer patients?
    Zheng, Zhiyuan
    Onukwugha, Ebere
    Hanna, Nader
    Reese, Emily S.
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer
    Attard, C. L.
    Brown, S.
    Alloul, K.
    Moore, M. J.
    [J]. CURRENT ONCOLOGY, 2014, 21 (01) : E41 - E51
  • [6] Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
    Zheng, Zhiyuan
    Hanna, Nader
    Onukwugha, Eberechukwu
    Reese, Emily S.
    Seal, Brian
    Mullins, C. Daniel
    [J]. CANCER MEDICINE, 2014, 3 (01): : 124 - 133
  • [7] Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer.
    Attard, Cheryl L.
    Brown, Stephen
    Alloul, Karine
    Moore, Malcolm J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [8] COST-EFFECTIVENESS ANALYSIS OF FULVESTRANT IN THE TREATMENT OF METASTATIC BREAST CANCER IN SECOND-LINE CHEMOTHERAPY
    Krysanov, I
    Krysanova, V
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A637 - A637
  • [9] The Impact of Comorbidity on Costs and Effects of Second-line Treatment among Elderly Metastatic Colon Cancer Patients
    Woldemichael, A.
    Onukwugha, E.
    Zheng, Z.
    Hanna, N.
    Seal, B. S.
    Mullins, C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S139 - S139
  • [10] Cost-effectiveness of maintenance therapy after first-line treatment in metastatic colorectal cancer
    Giuliani, Jacopo
    Mantoan, Beatrice
    Bonetti, Andrea
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 194 - 198
12345